Unique ID issued by UMIN | UMIN000048227 |
---|---|
Receipt number | R000054961 |
Scientific Title | Verification of the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patients |
Date of disclosure of the study information | 2022/07/01 |
Last modified on | 2024/01/01 09:24:49 |
Verification of the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patients
Verification of the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patients
Verification of the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patients
Verification of the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patients
Japan |
End-stage renal failure
Nephrology |
Others
NO
We will examine the effect of sacubitril valsartan sodium hydrate on the residual renal function of peritoneal dialysis patients.
Efficacy
Confirmatory
Pragmatic
Not applicable
Comparison of the rate of decrease in residual renal function in each group after 6 months of distribution to 3 groups.
Comparison of blood pressure in each group after 6 months of distribution to 3 groups
.Comparison of cardiac function (EF) by Biplane Modified Simpson method in each group after 6 months of 3 groups.Comparison of peritoneal function in each group after 6 months of distribution to 3 groups.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
No treatment
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
YES
No need to know
3
Treatment
Medicine |
Test group: Sacubitril valsartan sodium hydrate use group.
ARB group: RAS inhibitor use group.
Control group: Sacubitril valsartan sodium hydrate and no RAS inhibitor.
20 | years-old | <= |
90 | years-old | > |
Male and Female
This study targets peritoneal patients who are visiting the International University of Health and Welfare Hospital, the International University of Health and Welfare Narita Hospital, and the Keio University Hospital, and who have consented to participate in the study.Patients should be less than 3 months after the introduction of peritoneal dialysis.
Those who did not consent to participate in the study.
45
1st name | Naoki |
Middle name | |
Last name | Washida |
International University of Health and Welfare Narita Hospital
Department of Nephrology
286-8520
IUHW Narita Hospital 852 Hatakeda, Narita City, Chiba 286-8520 Japan
0476-35-5600
washida@iuhw.ac.jp
1st name | Kazuya |
Middle name | |
Last name | Sugita |
International University of Health and Welfare
Kidney Internal Medicine Course
329-2763
537-3 Iguchi, Nasushiobara City, Tochigi Prefecture
08031522251
ksugita0425@yahoo.co.jp
International University of Health and Welfare
International University of Health and Welfare
Other
International University of Health and Welfare
537-3 Iguchi, Nasushiobara City, Tochigi Prefecture
08031522251
ksugita0425@yahoo.co.jp
NO
2022 | Year | 07 | Month | 01 | Day |
Unpublished
Open public recruiting
2022 | Year | 07 | Month | 01 | Day |
2022 | Year | 07 | Month | 01 | Day |
2022 | Year | 07 | Month | 01 | Day |
2026 | Year | 03 | Month | 31 | Day |
2026 | Year | 03 | Month | 31 | Day |
2026 | Year | 03 | Month | 31 | Day |
2022 | Year | 07 | Month | 01 | Day |
2024 | Year | 01 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000054961